Brief: Intervacc AB Receives Positive CVMP Opinion For Strangvac, A Vaccine Against Equine Strangles, In EU

Intervacc AB

17/06/2021 21:05

June 17 (Reuters) - Intervacc AB  IVACC.ST :
    * RECEIVES POSITIVE CVMP OPINION FOR STRANGVAC, A VACCINE
AGAINST
EQUINE STRANGLES, IN EU
    * ENDORSEMENT OF POSITIVE OPINION BY EUROPEAN COMMISSION IS
EXPECTED IN Q3 OF 2021
    * PROCESS TOWARDS APPROVAL OF STRANGVAC FOR USE IN UK IS
ON-TRACK
AND COMPANY ANTICIPATES RECEIVING A POSITIVE OPINION BEFORE END
OF JULY

Source text for Eikon:  ID:nWkr44FKJZ 
Further company coverage:  IVACC.ST 

 ((Reuters.Briefs@thomsonreuters.com;))